- Conditions
- Chronic Plaque Psoriasis
- Interventions
- ARQ-151 0.3% cream, ARQ-151 vehicle cream
- Drug
- Lead sponsor
- Arcutis Biotherapeutics, Inc.
- Industry
- Eligibility
- 2 Years and older
- Enrollment
- 442 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 31
- States / cities
- Scottsdale, Arizona • Beverly Hills, California • Encino, California + 26 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 86
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Primary Open-angle Glaucoma (POAG), Ocular Hypertension
- Interventions
- SHP639 (n=60), Placebo Comparator (n=24)
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 63 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- Lexington, Massachusetts
- Conditions
- BCCs in Gorlin Syndrome Patients
- Interventions
- PTX-022, Vehicle comparator
- Drug
- Lead sponsor
- Palvella Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 73 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 14
- States / cities
- Scottsdale, Arizona • Hot Springs, Arkansas • Palo Alto, California + 11 more
- Conditions
- Hypertension, Diabetes Type 2
- Interventions
- Sitagliptin (DPP4 inhibitor), Substance P,, bradykinin, enalaprilat (ACE inhibitor), Glucagon-like peptide 1, brain natriuretic peptide
- Drug
- Lead sponsor
- Vanderbilt University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 44 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Tinea Pedis
- Interventions
- Experimental Drug SESC 01, Placebo, Terbinafine Hydrochloride
- Drug
- Lead sponsor
- South End Skin Care
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017
- U.S. locations
- 1
- States / cities
- Milford, Massachusetts
- Conditions
- Preoperative Skin Preparation
- Interventions
- Chlorhexidine gluconate, N,N'-(1,10-decanediyldi-1(4H)-Pyridinyl-4-ylidene)-Bis-(1-octanamine) Dihydrochloride, Placebo
- Drug
- Lead sponsor
- C. R. Bard
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 145 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- Butte, Montana
- Conditions
- Diabetic Foot Ulcer
- Interventions
- ALLO-ASC-DFU, Hydrogel SHEET(Vehicle control)
- Biological · Procedure
- Lead sponsor
- Anterogen Co., Ltd.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 66 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- External Genital Warts
- Interventions
- Investigational Treatment, Aldara
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 60 Years · Male only
- Enrollment
- 88 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 1
- States / cities
- Arlington Heights, Illinois
- Conditions
- Plaque Psoriasis
- Interventions
- calcitriol ointment, placebo comparator
- Drug
- Lead sponsor
- Galderma R&D
- Industry
- Eligibility
- 2 Years to 12 Years
- Enrollment
- 19 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 12
- States / cities
- Beverly Hills, California • Sacramento, California • Louisville, Kentucky + 9 more
- Conditions
- Diabetic Foot Ulcer, Infection
- Interventions
- PluroGel N, PluroGel
- Drug
- Lead sponsor
- PluroGen Therapeutics, Inc
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 15
- States / cities
- Phoenix, Arizona • Los Angeles, California • Oakland, California + 8 more
- Conditions
- Dry Eye Disease
- Interventions
- SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), Mycophenolic Acid 0.1%, Mycophenolic Acid 0.3%, Betamethasone Sodium Phosphate 0.01%, Placebo Comparator: Vehicle, Cyclosporine 0.05% Ophthalmic Emulsion, Lifitegrast 5% Ophthalmic Solution
- Drug
- Lead sponsor
- Surface Ophthalmics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 349 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 40
- States / cities
- Phoenix, Arizona • Azusa, California • Hemet, California + 33 more
- Conditions
- Nasal Allergies, Allergies
- Interventions
- AL-53817 nasal spray solution, Vehicle nasal spray
- Drug · Other
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 110 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Atopic Dermatitis
- Interventions
- FMX114, Vehicle
- Drug · Other
- Lead sponsor
- Vyne Therapeutics Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 4
- States / cities
- Miami, Florida • Miramar, Florida • Sugarloaf, Pennsylvania
- Conditions
- Eyes Dry Chronic
- Interventions
- ESBA105 ophthalmic solution, ESBA105 vehicle
- Biological · Other
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 334 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Atelectasis, Ventilation, Mechanical
- Interventions
- Pulmozyme (nebulized dornase alpha), Saline
- Drug
- Lead sponsor
- University of Medicine and Dentistry of New Jersey
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Newark, New Jersey
- Conditions
- Acute Ischemic Stroke, Cerebral Stroke
- Interventions
- Drug: Normal Saline, Sovateltide
- Drug
- Lead sponsor
- Pharmazz, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 514 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 14
- States / cities
- Tucson, Arizona • Carmichael, California • Oxnard, California + 10 more
- Conditions
- Dry Eye Syndrome
- Interventions
- SkQ1 Vehicle Solution, SkQ1 Ophthalmic Solution
- Drug
- Lead sponsor
- Mitotech, SA
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 610 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 4
- States / cities
- Sun City West, Arizona • Andover, Massachusetts • San Antonio, Texas + 1 more
- Conditions
- Vulvar and Vaginal Atrophy
- Interventions
- Estrace® Cream, Estradiol Vaginal Cream, Vehicle Cream
- Drug
- Lead sponsor
- Prasco LLC
- Industry
- Eligibility
- 30 Years to 75 Years · Female only
- Enrollment
- 540 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 27
- States / cities
- Sacramento, California • San Diego, California • Denver, Colorado + 23 more
- Conditions
- Stroke, Acute
- Interventions
- Nerinetide (NA-1), 2.6 mg/kg, Placebo
- Drug
- Lead sponsor
- NoNO Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,105 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 20
- States / cities
- Los Angeles, California • San Francisco, California • Torrance, California + 17 more
- Conditions
- Acne Vulgaris
- Interventions
- SB204 4%, Vehicle Gel
- Drug
- Lead sponsor
- Novan, Inc.
- Industry
- Eligibility
- 9 Years to 99 Years
- Enrollment
- 1,307 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016
- U.S. locations
- 55
- States / cities
- Anaheim, California • Encinitas, California • Fresno, California + 47 more
- Conditions
- Dry Eye Disease
- Interventions
- GRF312 5%, Placebo Comparator
- Drug · Other
- Lead sponsor
- Instituto Grifols, S.A.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 103 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 10
- States / cities
- Glendale, California • Grove, California • Newport Beach, California + 7 more
- Conditions
- Glaucoma, Open-Angle, Ocular Hypertension
- Interventions
- Bimatoprost SR, Sham: Applicator Without Needle, Active Comparator: Timolol 0.5%, Timolol Vehicle (placebo)
- Drug · Other
- Lead sponsor
- Allergan
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 528 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2020
- U.S. locations
- 51
- States / cities
- Dothan, Alabama • Chandler, Arizona • Fayetteville, Arkansas + 47 more
- Conditions
- Chronic Hand Eczema
- Interventions
- ARQ-252 cream 0.3%, ARQ-252 cream 0.1%, ARQ-252 Vehicle Cream
- Drug
- Lead sponsor
- Arcutis Biotherapeutics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 230 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 25
- States / cities
- Beverly Hills, California • Encino, California • Fremont, California + 21 more
- Conditions
- Actinic Keratoses
- Interventions
- Test Product (A): Fluorouracil Cream, 5% topical cream, Reference Product (B): Fluorouracil 5% Topical Cream of Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Placebo Product (C): Test vehicle cream for fluorouracil 5% of Encube Ethicals Pvt. Ltd., India
- Drug
- Lead sponsor
- Encube Ethicals Pvt. Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 458 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022
- U.S. locations
- 7
- States / cities
- Bakersfield, California • Cerritos, California • Lauderdale Lakes, Florida + 3 more